New Search Download PDF Cause medicine
Alastruey-Izquierdo A, Alcazar-Fuoli L, Rivero-Menéndez O, Ayats J, Castro C, García-Rodríguez J, Goterris-Bonet L, Ibáñez-Martínez E, Linares-Sicilia MJ, Martin-Gomez MT, Martín-Mazuelos E, Pelaez T, Peman J, Rezusta A, Rojo S, Tejero R, Anza DV, Viñuelas J, Zapico MS, Cuenca-Estrella M, the FILPOP2 Project from GEMICOMED (SEIMC) and REIPI (2018)
Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)
Antimicrob Agents Chemother. 2018 Aug 27;62(9)
pp. e00358–18
Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)

Candida albicans, oral isolate, rice, days, 630x resolution

Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)

Candida albicans, stool isolate, SG plate, margin, 400x magnification

Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)

Candida glabrata, urine isolate, SG margin, 400x magnification, contrast

Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)

Candida kefyr, stool isolate, SG, 1 day, margin, 400x magnification

Aspergillus; Fusarium; Mucorales; Scedosporium; TR34/L98H; antifungal resistance; aspergillosis; azole resistance; cryptic species; cyp51A

Check-ups for pathogenic yeasts

Causal medical examination and treatment of pathogenic fungal infections.

CONTACT